Newsletter | June 19, 2025

06.19.25 -- A Common Sense Approach To Sustainability In The Biosimilar Business

SPONSOR

The PDA Regulatory Conference 2025 Achieving CGMP Excellence: Sustainable Compliance Across the Lifecycle continues its 34-year tradition of delivering impactful content that supports the development and implementation of effective quality systems across the product lifecycle. This premier pharmaceutical CGMP conference on 08-10 September 2025 in Washington, DC will focus on strategies to manage manufacturing and quality risks while driving operational excellence and sustainable compliance. Register Now

FEATURED EDITORIAL

From Preparation To Compliance: DSCSA Implementation Takes Big Steps In 2025

The phased exemption periods of the Drug Supply Chain Security Act (DSCSA) expire on different dates throughout 2025 (including one quickly approaching in May), marking a series of milestones for implementation.

Hard Lessons In Parenteral Automatic Visual Inspection

Complex problems can have simple solutions. That's what a team at AstraZeneca found when they set out to reduce false rejection rates in vials containing mAbs.

A Road Map For PAT Monitoring And Control

Process analytic technology monitoring and control is rapidly progressing. BioPhorum shares new best practices on how to move from concept through life cycle management and/or regulatory approval of the PAT application.

INDUSTRY INSIGHTS

A Common Sense Approach To Sustainability In The Biosimilar Business

Through common sense and creative thinking, examine how the industry can discover new ways to achieve success and sustainability in the biosimilar market.

SOLUTIONS

Viral Clearance Studies To Meet Your Timelines